PMD Device Solutions AB (OSTO:PMDS) Accounts Payable: kr32.34 Mil (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:PMDS PMD Device Solutions AB OSTO:PMDS
4 GF Score
Price kr0.66
View Full Analysis

What is PMD Device Solutions AB Accounts Payable?

PMD Device Solutions AB OSTO:PMDS 4 Accounts Payable is kr32.34 Mil as of Sep. 2024. GuruFocus rates OSTO:PMDS with a GF Score™ of 4/100.

PMD Device Solutions AB's Accounts Payable for the quarter that ended in Sep. 2024 was kr32.34 Mil.

PMD Device Solutions AB's quarterly Accounts Payable increased from Mar. 2024 (kr21.34 Mil) to Jun. 2024 (kr24.52 Mil) and increased from Jun. 2024 (kr24.52 Mil) to Sep. 2024 (kr32.34 Mil).

PMD Device Solutions AB's annual Accounts Payable increased from Dec. 2021 (kr4.00 Mil) to Dec. 2022 (kr4.72 Mil) and increased from Dec. 2022 (kr4.72 Mil) to Dec. 2023 (kr20.07 Mil).

PMD Device Solutions AB Accounts Payable Related Terms

PMD Device Solutions AB Accounts Payable Historical Data

* Premium members only.

The historical data trend for PMD Device Solutions AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PMD Device Solutions AB Accounts Payable Chart

PMD Device Solutions AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial 12.23 1.02 4.00 4.72 20.07

PMD Device Solutions AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 20.07 21.34 24.52 32.34
OSTO:PMDS
4GF Score
PMD Device Solutions AB OSTO:PMDS
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PMD Device Solutions AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of kr32.34 Mil mean?
PMD Device Solutions AB (OSTO:PMDS) has a Accounts Payable of kr32.34 Mil as of Sep. 2024. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PMD Device Solutions AB and its competitors.
Is PMD Device Solutions AB's Accounts Payable too high?
PMD Device Solutions AB's current Accounts Payable is kr32.34 Mil. Overall, PMD Device Solutions AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does PMD Device Solutions AB's Accounts Payable compare to ABT and SYK?
PMD Device Solutions AB's Accounts Payable of kr32.34 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PMD Device Solutions AB and its competitors. PMD Device Solutions AB's current Accounts Payable is kr32.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMD Device Solutions AB stock overvalued right now?
PMD Device Solutions AB (OSTO:PMDS) has a current Accounts Payable of kr32.34 Mil. The current Accounts Payable is kr32.34 Mil. PMD Device Solutions AB's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For PMD Device Solutions AB (OSTO:PMDS), the current Accounts Payable is kr32.34 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PMD Device Solutions AB Business Description

Address C/o Eversheds Sutherland Advokatbyra AB, Box 14055, Stockholm, SWE, 104 40
PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to detect deterioration of a patient's general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company's knowledge, the world's only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA-cleared in the US.
4GF Score

Get the complete analysis for OSTO:PMDS

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.66
Price